Key result
Ischemic cardiomyopathy was associated with more severe functional mitral regurgitation compared to nonischemic dilated cardiomyopathy (mean ERO 0.16 vs 0.12 cm2, P=0.002).
Why the study?
What are the primary determinants of functional mitral regurgitation severity in patients with ischemic versus nonischemic dilated cardiomyopathy?
Observational (n=103)
What are the primary determinants of functional mitral regurgitation severity in patients with ischemic versus nonischemic dilated cardiomyopathy?
Functional mitral regurgitation severity is primarily determined by mitral apparatus deformity, specifically coaptation height, with ischemic cardiomyopathy patients exhibiting more severe MR than nonischemic patients.
Answers are grounded in this paper and cite their sources.
May support etiology-specific MR monitoring in cardiomyopathy; leaves open whether coaptation height drives the severity difference.
AIMS: Functional mitral regurgitation (MR) is prevalent among patients with left ventricular (LV) dysfunction and is associated with a poorer prognosis. Our aim was to assess the primary determinants of MR severity in patients with ischemic cardiomyopathy (ICM) and nonischemic dilated cardiomyopathy (DCM). METHODS AND RESULTS: Patients with functional MR secondary to ICM (n = 55) and DCM (n = 48) were prospectively enrolled. Effective regurgitant orifice (ERO) area, global LV remodeling, regional wall-motion abnormalities, and mitral apparatus deformity indices were assessed utilizing conventional and tissue Doppler echocardiography. ICM patients had more severe MR compared with DCM patients despite similar ejection fraction and functional status (ERO = 0.16 ± 0.08 cm(2) vs. ERO = 0.12 ± 0.70 cm(2) , respectively, P = 0.002). Regional myocardial systolic velocities in mid-inferior and mid-lateral wall were negatively correlated with ERO in ICM and DCM patients, respectively. Multivariate analysis identified coaptation height as the only independent determinant of ERO in both groups. In a subset of ICM patients (n = 9) with relatively high ERO despite low coaptation height, a higher prevalence of left bundle branch block was detected (88.9% vs. 46.7%, P = 0.02). CONCLUSIONS: Functional MR severity was chiefly determined by the extent of mitral apparatus deformity, and coaptation height can provide a rapid estimation of MR severity in heart failure patients. Additional contributory mechanisms in ICM patients include depressed myocardial systolic velocities in posteromedial papillary muscle attaching site and evidence of global LV dyssynchrony.
No takes yet. Share an insight, caveat, or question.
Konstantinou et al. (2013) conducted an observational in Functional mitral regurgitation in ischemic and nonischemic dilated cardiomyopathy (n=103). Ischemic cardiomyopathy vs. Nonischemic dilated cardiomyopathy was evaluated on Effective regurgitant orifice (ERO) area (p=0.002). Ischemic cardiomyopathy was associated with more severe functional mitral regurgitation compared to nonischemic dilated cardiomyopathy (mean ERO 0.16 vs 0.12 cm2, P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: